GLR-19

• CAS Number :

  1225014-05-0

• Target :

  HIV Protease|||HSV

• Related Pathways :

  Microbiology/Virology|||Proteases/Proteasome

• Bioactivity :

  GLR-19 is an anti-HIV peptide with demonstrated antiviral activity against HSV-2 [1] [2].

• Smiles :

  [C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(=N)N)C(O)=O)=O)CC(C)C)=O)CC(C)C)=O)CC(C)C)=O)CCCNC(=N)N)=O)=O)CC(C)C)=O)CCCNC(=N)N)=O)(NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CN)=O)CC(C)C)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CC(C)C)=O)CC(C)C)=O)=O)CCCNC(=N)N)=O)CC(C)C)=O)CC(C)C)=O)CCCNC(=N)N

• Molecular Formula :

  C102H194N40O20

• Molecular Weight :

  2300.89

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C